INTRAVESICAL α-RADIOIMMUNOTHERAPY OF HUMAN UROTHELIAL CARCINOMA IN AN ORTHOTOPIC XENOGRAFT MOUSE MODEL: A PROMISING NEW THERAPY FOR SUPERFICIAL BLADDER CANCER

被引：0
|
作者：
Autenrieth, M. [1 ]
Pfost, B. [2 ]
Seidl, C. [2 ]
Treiber, U. [1 ]
Gschwend, J. E. [1 ]
Senekowitsch-Schmidtke, R. [2 ]
机构：
[1] Tech Univ Munich, Rechts Isar Med Ctr, Dept Urol, Munich, Germany
[2] Tech Univ Munich, Rechts Isar Med Ctr, Dept Nucl Med, Munich, Germany
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2010年 / 9卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(10)60910-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：292 / 292
页数：1
相关论文
共 50 条
  • [21] ENHANCED ANTITUMOR EFFECT OF INTRAVESICAL BCG PLUS DOCETAXEL THERAPY IN AN ORTHOTOPIC BLADDER CANCER MODEL
    Horinaga, Minoru
    Fukuyama, Ryuichi
    Iida, Masahiro
    Matsushima, Masashi
    Yanaihara, Hitoshi
    Nakahira, Yoko
    Ueno, Munehisa
    Asakura, Hirotaka
    JOURNAL OF UROLOGY, 2011, 185 (04): : E212 - E212
  • [22] Intravesical anti-PD-1 immune checkpoint inhibition in urothelial bladder cancer in a mouse model
    Rajkumar, Anne
    Wang, Jian
    Neuzil, Kevin E.
    Kirschner, Austin Noah
    Chang, Sam S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [23] EXPERIMENTAL INTRAVESICAL THERAPY FOR SUPERFICIAL TRANSITIONAL CELL-CARCINOMA IN A RAT BLADDER-TUMOR MODEL
    STEINBERG, GD
    BRENDLER, CB
    SQUIRE, RA
    ISAACS, JT
    JOURNAL OF UROLOGY, 1991, 145 (03): : 647 - 653
  • [24] Preclinical Evaluation of Transcriptional Targeting Strategy for Human Hepatocellular Carcinoma in an Orthotopic Xenograft Mouse Model
    Sia, Kian Chuan
    Huynh, Hung
    Chung, Alexander Yaw Fui
    Ooi, London Lucien Peng Jin
    Lim, Kiat Hon
    Hui, Kam Man
    Lam, Paula Yeng Po
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (08) : 1651 - 1664
  • [25] Enhanced Antitumor Effect of Coincident Intravesical Gemcitabine Plus BCG Therapy in an Orthotopic Bladder Cancer Model
    Horinaga, Minoru
    Fukuyama, Ryuichi
    Iida, Masahiro
    Yanaihara, Hitoshi
    Nakahira, Yoko
    Nonaka, Shoichi
    Deguchi, Nobuhiro
    Asakura, Hirotaka
    UROLOGY, 2010, 76 (05) : 1267.e1 - 1267.e6
  • [26] ENHANCED ANTITUMOR EFFECT OF INTRAVESICAL BCG PLUS MMC THERAPY IN AN ORTHOTOPIC MURINE BLADDER CANCER MODEL
    Horinaga, Minoru
    Matsushima, Masashi
    Fukuyama, Ryuichi
    Yanaihara, Hitoshi
    Iida, Masahiro
    Nakahira, Yoko
    Asakura, Hirotaka
    JOURNAL OF UROLOGY, 2010, 183 (04): : E445 - E445
  • [27] ENHANCED ANTITUMOR EFFECT OF INTRAVESICAL GEMICITABINE THERAPY PLUS BCG IN AN ORTHOTOPIC MURINE BLADDER CANCER MODEL
    Horinaga, Minoru
    Fukuyama, Ryuichi
    Iida, Masahiro
    Yanaihara, Hitoshi
    Nakahira, Yoko
    Nonaka, Syoichi
    Deguchi, Nobuhiro
    JOURNAL OF UROLOGY, 2009, 181 (04): : 408 - 408
  • [28] Enhanced antitumor effect of combination intravesical BCG plus Docetaxel therapy in an orthotopic bladder cancer model
    Horinaga, Minoru
    Fukuyama, Ryuichi
    Iida, Masahiro
    Matsushima, Masashi
    Yanaihara, Hiroshi
    Nakahira, Yoko
    Ueno, Munehisa
    Asakura, Hirotaka
    CANCER RESEARCH, 2011, 71
  • [29] THE DEVELOPMENT OF LIPOSOMES CONTAINING INTERFERON-ALPHA FOR THE INTRAVESICAL THERAPY OF HUMAN SUPERFICIAL BLADDER-CANCER
    FRANGOS, DN
    KILLION, JJ
    FAN, D
    FISHBECK, R
    VONESCHENBACH, AC
    FIDLER, IJ
    JOURNAL OF UROLOGY, 1990, 143 (06): : 1252 - 1256
  • [30] Intravesical Anti-PD-1 Immune Checkpoint Inhibition Treats Urothelial Bladder Cancer in a Mouse Model
    Kirschner, Austin N.
    Wang, Jian
    Rajkumar-Calkins, Anne
    Neuzil, Kevin E.
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2021, 205 (05): : 1336 - 1343
12345